ChromoGenics AB
Символ: CHRO.ST
STO
7
SEKПазарна цена днес
-0.4925
Съотношение P/E
-0.0087
Коефициент PEG
28.87M
MRK Cap
- 0.00%
Доходност на DIV
ChromoGenics AB (CHRO-ST) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 50.56 | 7.9 | 24.1 | 18.9 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.net-receivables | 48.47 | 11.7 | 11.7 | 13.7 | ||||||||||
balance-sheet.row.inventory | 44.97 | 10.2 | 10.2 | 11 | ||||||||||
balance-sheet.row.other-current-assets | 24.51 | 9 | 0.1 | 2.2 | ||||||||||
balance-sheet.row.total-current-assets | 144 | 29.8 | 46 | 45.7 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 403.39 | 98.3 | 103 | 101.8 | ||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0.6 | 1.5 | ||||||||||
balance-sheet.row.intangible-assets | 46.45 | 10.7 | 11.7 | 9 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 46.45 | 10.7 | 12.3 | 10.5 | ||||||||||
balance-sheet.row.long-term-investments | 1.73 | 0.4 | 0.4 | 0 | ||||||||||
balance-sheet.row.tax-assets | -1.73 | -0.4 | 0 | 0 | ||||||||||
balance-sheet.row.other-non-current-assets | -227.05 | 0.4 | -0.3 | 2.5 | ||||||||||
balance-sheet.row.total-non-current-assets | 451.57 | 109.4 | 115.5 | 114.8 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 595.56 | 139.2 | 161.5 | 160.4 | ||||||||||
balance-sheet.row.account-payables | 20.72 | 2.8 | 8.6 | 7.8 | ||||||||||
balance-sheet.row.short-term-debt | 1.02 | 0.2 | 0.3 | 15.4 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 265.55 | 66.6 | 63.8 | 46.3 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 82.42 | 24.4 | 15.9 | 3.4 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 272.76 | 66.6 | 66.2 | 50.1 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-liab | 376.92 | 94 | 91 | 102.7 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 138.74 | 35.1 | 28.7 | 3.4 | ||||||||||
balance-sheet.row.retained-earnings | -2776.12 | -715.4 | -661.1 | -601.7 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 37.62 | 9.9 | 8.1 | 5.6 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 2815.97 | 713.2 | 694.8 | 650.3 | ||||||||||
balance-sheet.row.total-stockholders-equity | 216.22 | 42.8 | 70.5 | 57.7 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 595.56 | 139.2 | 161.5 | 160.4 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 216.22 | 42.8 | 70.5 | 57.7 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 595.56 | - | - | - | ||||||||||
Total Investments | 1.73 | 0.4 | 0.4 | 2.5 | ||||||||||
balance-sheet.row.total-debt | 266.57 | 66.8 | 64.1 | 61.7 | ||||||||||
balance-sheet.row.net-debt | 216.02 | 58.9 | 40 | 42.8 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -49.86 | -52.5 | -55.9 | -59.7 | ||||||||||
cash-flows.row.depreciation-and-amortization | 4.47 | 4.5 | 3.4 | 2.3 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.change-in-working-capital | 2.78 | 4.5 | -5.8 | 2.5 | ||||||||||
cash-flows.row.account-receivables | 0.07 | 0.1 | 6.1 | -3.8 | ||||||||||
cash-flows.row.inventory | 0.02 | 0 | 0.8 | -2.8 | ||||||||||
cash-flows.row.account-payables | -5.84 | -5.8 | 0.8 | -0.4 | ||||||||||
cash-flows.row.other-working-capital | 8.53 | 10.3 | -13.6 | 9.4 | ||||||||||
cash-flows.row.other-non-cash-items | 2.8 | 2.7 | -0.9 | -3.9 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -42.09 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.51 | -0.1 | -4.9 | -16 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -0.14 | -0.1 | -4.9 | -16 | ||||||||||
cash-flows.row.debt-repayment | -6.52 | 0 | -0.3 | -0.1 | ||||||||||
cash-flows.row.common-stock-issued | 24.77 | 24.8 | 69.8 | 0.3 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-financing-activites | 30.68 | 0 | 69.5 | 0.2 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 26.03 | 24.8 | 69.5 | 0.2 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.net-change-in-cash | -16.2 | -16.2 | 5.3 | -74.5 | ||||||||||
cash-flows.row.cash-at-end-of-period | 50.55 | 7.9 | 24.1 | 18.9 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 66.76 | 24.1 | 18.9 | 93.4 | ||||||||||
cash-flows.row.operating-cash-flow | -42.09 | -40.8 | -59.3 | -58.8 | ||||||||||
cash-flows.row.capital-expenditure | -0.51 | -0.1 | -4.9 | -16 | ||||||||||
cash-flows.row.free-cash-flow | -42.6 | -41 | -64.2 | -74.7 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 13.64 | 13.6 | 18.3 | 24.7 | ||||||||||
income-statement-row.row.cost-of-revenue | 23.81 | 64.3 | 15 | 15.9 | ||||||||||
income-statement-row.row.gross-profit | -10.16 | -50.6 | 3.3 | 8.7 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 7.26 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 7.01 | 0 | 29 | 25.1 | ||||||||||
income-statement-row.row.operating-expenses | 55.82 | 55.8 | 60.8 | 69.6 | ||||||||||
income-statement-row.row.cost-and-expenses | 63.79 | 64.3 | 75.8 | 85.6 | ||||||||||
income-statement-row.row.interest-income | 0.44 | 0.5 | 0.6 | 0.1 | ||||||||||
income-statement-row.row.interest-expense | 4.2 | 4.3 | 1.7 | 4 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | -2.36 | -1.9 | 0.6 | -2.7 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 7.01 | 0 | 29 | 25.1 | ||||||||||
income-statement-row.row.total-operating-expenses | -2.36 | -1.9 | 0.6 | -2.7 | ||||||||||
income-statement-row.row.interest-expense | 4.2 | 4.3 | 1.7 | 4 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 4.55 | 4.5 | 5 | 3.4 | ||||||||||
income-statement-row.row.ebitda-caps | -45.34 | - | - | - | ||||||||||
income-statement-row.row.operating-income | -50.14 | -50.6 | -57.5 | -60.9 | ||||||||||
income-statement-row.row.income-before-tax | -52.51 | -52.5 | -57 | -63.5 | ||||||||||
income-statement-row.row.income-tax-expense | 0.9 | 0 | -0.6 | 3.8 | ||||||||||
income-statement-row.row.net-income | -53.38 | -52.5 | -56.4 | -67.3 |
Често задавани въпроси
Какво е ChromoGenics AB (CHRO.ST) общи активи?
ChromoGenics AB (CHRO.ST) общите активи са 139163000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 4104000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -10.337.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -10.337.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -3.912.
Какъв е общият приход на предприятието?
Общият приход е -3.675.
Каква е ChromoGenics AB (CHRO.ST) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -52506000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 66819999.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 55824000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 7926000.000.